Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,475 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of the Portuguese version of the Movement Disorder Society non-motor rating scale (MDS-NMS) in Parkinson's disease.
Vale TC, Santos DP, Oliveira DS, Paula Brandão PR, Pereira DA, Bouça-Machado R, Silva LO, Mello Rieder CR, Barbosa ER, Cury RG, Parmera JB, Ghizoni Teive HA, Ferreira MG, Ferraz HB, Candeias da Silva C, Tumas V, Nunes Cunha AL, Braga-Neto P, Lima DP, Della Colleta MV, Maia D, de Souza Fontana M, Damas CN, Lobo PP, Rebordão L, Magalhães AD, Peralta AR, Simões RM, Lampreia T, Velon AG, Carneiro D, Raimundo R, Gago M, Mendes A, Chã NV, Damásio J, Costa S, Lopes R, Morgadinho A, Mestre T, Stebbins GT, Luo S, Goetz CG, Ferreira JJ, Cardoso F; MDS-NMS Portuguese Validation Study Group. Vale TC, et al. Among authors: cardoso f. Parkinsonism Relat Disord. 2025 Jan 13;132:107276. doi: 10.1016/j.parkreldis.2025.107276. Online ahead of print. Parkinsonism Relat Disord. 2025. PMID: 39848139
Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2- breast cancer: a randomized phase 3 trial.
Cardoso F, O'Shaughnessy J, Liu Z, McArthur H, Schmid P, Cortes J, Harbeck N, Telli ML, Cescon DW, Fasching PA, Shao Z, Loirat D, Park YH, Fernandez MG, Rubovszky G, Spring L, Im SA, Hui R, Takano T, André F, Yasojima H, Ding Y, Jia L, Karantza V, Tryfonidis K, Bardia A. Cardoso F, et al. Nat Med. 2025 Jan 21. doi: 10.1038/s41591-024-03415-7. Online ahead of print. Nat Med. 2025. PMID: 39838117
Neurology pioneers in Japan.
Teive HAG, Coutinho L, Cardoso FEC, Tsuji S. Teive HAG, et al. Among authors: cardoso fec. Arq Neuropsiquiatr. 2025 Jan;83(1):1-3. doi: 10.1055/s-0044-1791661. Epub 2025 Jan 15. Arq Neuropsiquiatr. 2025. PMID: 39814005 Free article. English.
[Pharmacovigilance of COVID-19 Vaccines in Brazil: Actions Taken, Lessons Learned, and Next StepsFarmacovigilancia de las vacunas contra la COVID-19 en Brasil: medidas adoptadas, enseñanzas extraídas y próximos pasos].
Silva RMA, Cabral CM, Percio J, da Nóbrega MEB, Kobayashi CD, Martins AF, Cardoso FD, Porto VBG, Capovilla L, de Moraes MB, Andrade PHS, Fernandes EG. Silva RMA, et al. Among authors: cardoso fd. Rev Panam Salud Publica. 2025 Jan 13;49:e1. doi: 10.26633/RPSP.2025.1. eCollection 2025. Rev Panam Salud Publica. 2025. PMID: 39811044 Free PMC article. Portuguese.
The α-synuclein seed amplification assay: Interpreting a test of Parkinson's pathology.
Espay AJ, Lees AJ, Cardoso F, Frucht SJ, Erskine D, Sandoval IM, Bernal-Conde LD, Sturchio A, Imarisio A, Hoffmann C, Montemagno KT, Milovanovic D, Halliday GM, Manfredsson FP. Espay AJ, et al. Among authors: cardoso f. Parkinsonism Relat Disord. 2024 Dec 27:107256. doi: 10.1016/j.parkreldis.2024.107256. Online ahead of print. Parkinsonism Relat Disord. 2024. PMID: 39794217
1,475 results